Worldwide Assessment of Low- and Middle-Income Countries' Regulatory Preparedness to Approve Medical Products During Public Health Emergencies
Background: Regulatory preparedness for public health emergencies is critical. However, responses to past emergencies, such as the 2009 H1N1 influenza pandemic and medical product shortages, have revealed sizable gaps in countries' regulatory capacity and preparedness. A systematic analysis of...
Main Authors: | Alireza Khadem Broojerdi, Claudia Alfonso, Razieh Ostad Ali Dehaghi, Mohamed Refaat, Hiiti Baran Sillo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.722872/full |
Similar Items
-
The World Health Organization Global Benchmarking Tool an Instrument to Strengthen Medical Products Regulation and Promote Universal Health Coverage
by: Alireza Khadem Broojerdi, et al.
Published: (2020-08-01) -
Product Complexity and Strategic Alliance on Drug Approval
by: Taoyong Su, et al.
Published: (2021-05-01) -
Disease modification in osteoarthritis; pathways to drug approval
by: Jeffrey N. Katz, et al.
Published: (2020-06-01) -
Analysis of the Regulatory Science Applied to a Single Portfolio of Eight Biosimilar Product Approvals by Four Key Regulatory Authorities
by: Beverly Ingram, et al.
Published: (2021-04-01) -
Evaluation of the Review Models and Approval Timelines of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward
by: Tariro Sithole, et al.
Published: (2021-08-01)